Your browser doesn't support javascript.
loading
Estimating the overall survival benefit of adjuvant chemo-endocrine therapy in women over age 50 with pT1-2N0 early stage breast cancer and 21-gene recurrence score ≥26: A National Cancer Database analysis.
Stabellini, Nickolas; Cao, Lifen; Towe, Christopher W; Amin, Amanda L; Montero, Alberto J.
Afiliação
  • Stabellini N; Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • Cao L; Faculdade Israelita de Ciências da Saúde Albert Einstein, Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • Towe CW; Division of Hematology and Oncology, Department of Medicine, University Hospitals/Seidman Cancer Center, Case Western Reserve University School of Medicine, Ohio, Cleveland, USA.
  • Amin AL; Division of Thoracic and Esophageal Surgery, Department of Surgery, University Hospitals Research in Surgical Outcomes and Effectiveness (UH-RISES), University Hospitals/Seidman Cancer Center, Case Western Reserve University School of Medicine, Ohio, Cleveland, USA.
  • Montero AJ; Division of Surgical Oncology, Department of Surgery, University Hospitals Research in Surgical Outcomes and Effectiveness (UH-RISES), University Hospitals/Seidman Cancer Center, Case Western Reserve University School of Medicine, Ohio, Cleveland, USA.
Cancer Med ; 12(19): 19607-19616, 2023 10.
Article em En | MEDLINE | ID: mdl-37766666
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Idioma: En Ano de publicação: 2023 Tipo de documento: Article